ARVN – arvinas, inc. (US:NASDAQ)
Stock Stats
News
Arvinas (NASDAQ:ARVN) was given a new $18.00 price target on by analysts at Barclays PLC. They now have an "overweight" rating on the stock.
How the Narrative Surrounding Pfizer Is Changing After Obesity Deals and Sector Rerating [Yahoo! Finance]
Arvinas (NASDAQ:ARVN) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition
Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Form 8-K ARVINAS, INC. For: Dec 06
Form SCHEDULE 13G ARVINAS, INC. Filed by: D. E. SHAW & CO, L.P.
Form SCHEDULE 13G/A ARVINAS, INC. Filed by: CITADEL ADVISORS LLC
Form 4 ARVINAS, INC. For: Nov 07 Filed by: Loomis David K
Form 10-Q ARVINAS, INC. For: Sep 30
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.